Close

Zogenix (ZGNX) Begins Clinical Efficacy Portion of Study 1504 for ZX008 in Dravet

February 13, 2017 8:05 AM EST Send to a Friend
Zogenix, Inc. (NASDAQ: ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login